Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a robotic arm and a test sample in a lab setting.

Jun 4, 2026

Inside SLAS Europe 2026: lab automation insights

SLAS Europe 2026 showcased significant advancements in lab automation and collaborative efforts in the life sciences sector.The event, held in Vienna, emphasized the critical role of collaboration in scientific progress, as highlighted by Dr. Johanna Huchting from the Fraunhofer Institute. She pointed out that the notion of the solitary genius is misleading; instead, collective efforts are essential for advancing research. The "State of the Industry" panel addressed how innovations in AI and aut
An open lab notebook and pen in a dimly lit laboratory setting.

Jun 4, 2026

Scispot Raises $8M Series A to Help Life Sciences Labs Move Faster

Scispot has successfully secured $8 million in Series A funding to enhance operational efficiency in life sciences labs.The Kitchener-Waterloo-based company, known for its AI-native operating layer, aims to streamline lab processes for over 100 labs in the biotech, pharma, and diagnostics sectors. The funding round, led by Avenue Growth Partners, will support Scispot's growth in product development and engineering, as well as expand its customer success teams.Scispot's platform addresses a criti
A minimalist representation of a heart and gear symbolizing healthcare automation.

Jun 4, 2026

Elation Health Acquires Aster to Advance AI Agent Capabilities for Primary Care

Elation Health has acquired Aster to enhance its AI capabilities in primary care, particularly focusing on automating healthcare processes.The acquisition of Aster, an AI-driven electronic health record (EHR) company with a specialization in women's health, marks a significant step for Elation Health. This move aims to bolster its development of an "agentic operating system" designed to autonomously manage tasks for clinicians and care teams, setting it apart from traditional AI assistants.This
A test tube with a bubbling chemical solution on a lab bench

Jun 4, 2026

Alnylam hops on AI train with up to $2B Inceptive partnership

Alnylam Pharmaceuticals has announced a significant partnership with Inceptive Nucleics, marking a strategic move to leverage generative AI in drug development, a trend increasingly embraced by the biopharma sector.The collaboration involves an initial investment of $30 million from Alnylam for access to Inceptive's machine learning platform, which is designed to streamline the discovery and development of drug candidates. This partnership has the potential to escalate in value to $2 billion, co
A minimalist representation of investment growth with coins and an upward arrow.

Jun 4, 2026

Tech.eu reports ‘Big picture’ and strong funding momentum

According to Tech.eu’s recent report, Ireland secured the ninth position in Europe for health tech investment in 2025, highlighting a robust funding landscape across various sectors including biotech and AI-enabled healthcare.The report, titled *European Tech 2025 – The Big Picture*, reveals that the UK led the market with significant investments totaling €2.5 billion, particularly in AI drug discovery and surgical robotics. Switzerland and Finland followed, with investments exceeding €1 billion
A stack of patient consent forms on a wooden desk in a softly lit office.

Jun 4, 2026

Novellia Lands $18 Mn Series A to Scale Its Patient-Powered Data Platform for Pharma Research

Novellia, a healthtech startup based in New York, has successfully secured $18 million in Series A funding to enhance its Patient-Powered Data Platform, aimed at improving access to patient-consented health data for pharmaceutical research.This funding round, led by Spark Capital with contributions from Khosla Ventures, Acrew Capital, Bling Capital, and TMV, brings Novellia's total funding to $28 million since its inception in 2023. The company has developed a platform that enables patients to s
Stylized upward arrow symbolizing stock growth with a circular base representing Vyjuvek.

Jun 4, 2026

A Look At Krystal Biotech (KRYS) Valuation After Vyjuvek Driven Earnings Beat And Pipeline Progress

Krystal Biotech (KRYS) has recently reported impressive first-quarter earnings for 2026, surpassing expectations with increased revenue attributed to the strong uptake of its product Vyjuvek. The company's stock has shown significant momentum, boasting a 128.6% total return over the past year and a 22.24% increase year-to-date. Following the earnings report, shares rose by 2.94%, indicating that investors are reassessing the growth potential and risks associated with both Vyjuvek and Krystal's b
Close-up of a car dashboard showing vehicle diagnostics

Jun 4, 2026

Vodafone and Geely Boost Connected Car Innovation in Europe

Vodafone Business has strengthened its partnership with Geely Technology Europe, focusing on advancing connected car technologies across Europe.The collaboration now includes a suite of services designed for enhanced vehicle connectivity, such as Internet in the Car, Mobile Private Networks, and Cloud Connect solutions. These innovations enable critical functionalities like diagnostics and over-the-air software updates, ensuring secure data transfer between vehicles and cloud servers. This capab
A minimalist representation of a hospital building in a dark color scheme.

Jun 4, 2026

Domo & Regional One Health Bring AI Healthcare Workflows to the Front Lines with AWS-Powered Platform

Domo has partnered with Regional One Health to enhance healthcare workflows through AI, leveraging AWS technology to transform data insights into actionable outcomes.This collaboration aims to streamline various healthcare processes, including hospital length of stay management and pharmacy data capture. By utilizing Amazon Web Services, the partnership has created AI-driven applications tailored for a Level-1 trauma center, emphasizing real-time operational efficiency.A notable application, Sma
A petri dish with cell culture on a lab bench

Jun 4, 2026

Scispot closes $8-million USD Series A to become the operating layer for life sciences labs

Kitchener-Waterloo-based Scispot has successfully raised $8 million USD in Series A funding aimed at revolutionizing life sciences labs with AI technology.The company is focused on streamlining the often disjointed processes in life sciences research, including experiment planning, execution, documentation, and inventory management. Scispot's platform enables labs to centralize and automate these tasks, which is particularly beneficial for drug development and pathology research. Co-founder and
A minimalist illustration of a chromosome and genome strand representing advancements in genomics research.

Jun 4, 2026

OpenAI GPT-Rosalind Update Brings Advanced AI Drug Discovery and Genomics Research Capabilities

OpenAI has unveiled a major update to its GPT-Rosalind model, enhancing its capabilities in drug discovery and genomics research.The June 3, 2026 announcement highlights advancements in the GPT-Rosalind series, which is tailored for life sciences research, particularly in drug discovery and genomics. This update integrates the sophisticated features of GPT 5.5, aiming to improve performance in critical areas such as medicinal chemistry and experimental biology. OpenAI emphasizes that progress in
An RNA molecule on a lab bench in a dimly lit laboratory setting.

Jun 4, 2026

AI Collaboration Puts Alnylam’s RNAi Pipeline Productivity In Focus

Alnylam Pharmaceuticals has entered a collaboration with Inceptive Nucleics to enhance RNA interference (RNAi) drug discovery through the application of generative AI models. This partnership aims to streamline the drug design process, potentially increasing the efficiency and speed of developing new therapeutics as part of Alnylam's broader strategy for 2030.The collaboration seeks to leverage Inceptive's expertise in AI to optimize RNAi drug design, thereby shortening the trial-and-error phase